<prompt> Contraindication of rota virus vaccine is -SC1DIntussusceptionSevere allergic ractionAll of above  <response>: Ans. is d i.e., All of aboveGuide to Contraindications1 and Precautions to Commonly Used VaccinesVaccineContraindicationsPrecautionsHepatitis B HepBo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero Infant weighing less than 2000 grams 4 lbs, 6.4 ozRotavirusRV5 RV1 o Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Severe combined immunodeficiency SCIDo History of intussusceptiono Moderate or severe acute illness with or without fevero Altered immunocompetence other than SCIDo Chronic gastrointestinal diseaseo Spina bifida or bladder exstrophyDiphtheria,tetanus, pertussisDTaPTetanus,diphtheria,pertussis TdapTetanus,diphtheria DT, Tdo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento For pertussis-containing vaccines: encephalopathy e.g., coma, decreased level of consc iousness, prolonged seizures not attributable to another identifiable cause within 7 days of administration of a previous dose of DTP or DTaP for DTaP; or of previous dose of DTP, DTaP, or Tdap for Tdapo Moderate or severe acute illness with or without fevero Guillain-Barre syndrome GBS within 6 weeks after a previous dose of tetanus toxoid-containing vaccineo Historyr of arthus-type hypersensitivity reactions after a previous dose of tetanus or diphtheria toxoid-containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid containing vaccineo For pertussis-containing vaccines: progressive or unstable neurologic disorder including infantile spasms for DTaP, uncontrolled seizures, or progressive encephalopathy until a treatment regimen has been established and the condition has stabilizedFor DTaP only:o Temperature of 105c F or higher 40.5degC or higher within 48 hours after vaccination with a previous dose of DTPDTaPo Collapse or shock-like state i.e., hypotonic hyporesponsive episode within 48 hours after receiving a previous dose of DTPDTaP o Seizure within 3 days after receiving a previous dose of DTP.DTaPo Persistent, inconsolable crying lasting 3 or more hours within 48 hours after receiving a previous dose of DTPDTaPHaemophilusinfluenzae type bHibo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Age younger than 6 weekso Moderate or severe acute illness with or without feverInactivatedpoliovirus vaccineIPVo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero PregnancyPneumococcal PCVI3 orPPSV23o For PCV13, severe allergic reaction e.g., anaphylaxis after a previous dose of PCV7 or PCV13 or to a vaccine component, including to any vaccine containing diphtheria toxoido For PPSV23, severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverMeasles, mumps,rubella MMRo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Known severe immunodeficiency e.g.. from hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, or long-term immunosuppressive therapyS or patients with human immunodeficiency virus infection who are severely i mmunocompromi sed o Pregnancyo Moderate or severe acute illness with or without fevero Recent within 11 months receipt of antibody-containing blood product specific interval depends on producto Histoiy of thrombocytopenia or thrombocytopenic purpurao Need for tuberculin skin testingYaricella Varo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Known severe immunodeficiency e.g., from hematologic and solid tumors, receipt of chemotherapy, primary or acquired immunodeficiency, or long-term immunosuppressive therapy5 or patients with HIV infection who are severely immunocomprom i sedo Pregnancyo Moderate or severe acute illness with or without fevero Recent within 11 months receipt of antibody-containing blood product specific interval depends on producto Receipt of specific antivirals i.e., acyclovir, famciclovir, or valaevclo- vir 24 hours before vaccination; avoid use of these antiviral drugs for 14 days after vaccinationHepatitis AHepAo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverInfluenza, inactivatedinjectable IIVo Severe allergic reaction e.g., anaphylaxis after a previous dose of any IIV or LAIV or to a vaccine component, including egg proteino Moderate or severe acute illness with or without fevero Histoiy of GBS within 6 weeks of previous influenza vaccinationo Persons who experience only hives with exposure to eggs may receive RIV if age 18-49 or, with additional safety precautions, IIV.Influenza,recombinant Riffo Severe allergic reaction e.g., anaphylaxis after a previous dose of RIV or to a vaccine component. RIV does not contain any egg proteino Moderate or severe acute illness with or without fevero History of GBS within 6 weeks of previous influenza vaccinationInfluenza, liveattenuatedLAIVo Severe allergic reaction e.g., anaphylaxis after a previous dose of IIV or LAIV or to a vaccine component, including egg proteino Conditions for which the ACIP recommend, against use, but which are not contraindications in vaccine package insert: immune suppression, certain chronic medical conditions such as asthma, diabetes, heart or kidney disease, and pregnancyo Moderate or severe acute illness with or without fever o History of GBS within 6 weeks of previous influenza vaccination o Receipt of specific antivirals i.e., amantadine, rimantadine, zanamivir, or oseltamivir 48 hours before vaccination. Avoid use of these antiviral drugs for 14 days after vaccinationHumanPapillomavirusHPVo Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero PregnancyMen ingococcal: conjugate MCV4, polysacch aride MPSV4o Severe allergic reaction e.g., anaphylaxis after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverZoster HZVo Severe allergic reaction e.g., anaphylaxis to a vaccine componento Known severe immunodeficiency e.g., from hematologic and solid tumors, receipt of chemotherapy, or long-term immunosuppressive therapy5 or patients with HIV infection who are severely immunocompromised,o Pregnancyo Moderate or severe acute illness with or without fevero Receipt of specific antivirals i.e., acyclovir, famciclovir, or valacyclovir 24 hours before vaccination; avoid use of these antiviral drugs for 14 days after vaccination. 